Jenkins et al. has suggested a prediction model that combines circulating D-dimer, F 1 + 2, VEGF or plasminogen activator inhibitor-1 (PAI-1) levels, as well as tumoral tissue factor (TF) expression to risk stratify for VTE in adult glioma patients23. Here, VEGFA is linked to glioma.